Injectable Dynamically Crosslinked Zwitterionic Hydrogels as a Viscosupplement for Osteoarthritis Treatment
ACS Applied Materials & Interfaces · 2026
DOI: 10.1021/acsami.6c15705 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2026. Verfasst von Nahieli Preciado Rivera und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, McMaster University, 1280 Main St. W., Hamilton, ONL8S 4L7, Canada. Hauptthemen laut MEDLINE: Hydrogels, Osteoarthritis, Viscosupplements. Die Arbeit nennt 70 Literaturangaben. Gefördert von: Natural Sciences and Engineering Research Council of Canada (NSERC).
Abstract (Originalsprache)
While hyaluronic acid-based viscosupplements have been widely used clinically for osteoarthritis treatment, their rapid in vivo degradation and variable biological interactions have led to inconsistent patient outcomes. Herein, we report the use of a dynamically crosslinked hydrazone-based zwitterionic hydrogel based on mixing hydrazide (ZH) and aldehyde (ZA) or ketone (ZK)-functionalized precursor polymers as an alternative to hyaluronic acid-based viscosupplements. Upon coinjection via a double-barrel syringe, the water-like precursor polymer solutions gel within ∼0.5–3 min. Relative to a leading hyaluronic acid-based product (Synvisc®), the dynamic zwitterionic hydrogels showed 10–50× higher compressive moduli, beneficial to mechanically support the joint while at the same time exhibiting a 5–9× higher reduction in the coefficient of friction at walking frequencies against an alumina surface over 400 cycles and a >25% lower coefficient of friction against ex vivo cartilage samples, all while also being easy to inject given the low initial viscosity of the precursor polymers. The hydrogel was noncytotoxic and showed minimal inflammatory responses when injected in vivo, with the ZA formulations persisting for >90 days postinjection compared to only days for conventional HA-based viscosupplements. Overall, zwitterionic dynamic hydrogels provide a combination of mechanical support, lubricity, and in vivo inertness/stability while being injectable, suggesting promise for clinical translation for osteoarthritis treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Engineering, McMaster University, 1280 Main St. W., Hamilton, ONL8S 4L7, Canada.
- Biomedical Engineering Institute, Faculty of Medicine, Université de Montréal, 2940 Chemin de Polytechnique, Montréal, QCH3T 1J4, Canada.
- Faculty of Pharmacy, Université de Montréal, 2940 Chemin de Polytechnique, Montréal, QCH3T 1J4, Canada.
ORCID-Profile: Xavier Banquy, Todd Hoare
Förderung
- Natural Sciences and Engineering Research Council of Canada (NSERC)
Zitieren
APA
Rivera, N. P., Jenkins, M., Pham, D. A., Garza Flores, N. A., McCabe, C., Saini, A., Randhawa, G. K., Tavakolian, M., Sood, S., Belchos, M., Jun, I., Banquy, X., & Hoare, T. (2026). Injectable Dynamically Crosslinked Zwitterionic Hydrogels as a Viscosupplement for Osteoarthritis Treatment. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.6c15705
Vancouver
Rivera NP, Jenkins M, Pham DA, Garza Flores NA, McCabe C, Saini A, et al. Injectable Dynamically Crosslinked Zwitterionic Hydrogels as a Viscosupplement for Osteoarthritis Treatment. ACS Applied Materials & Interfaces. 2026. doi:10.1021/acsami.6c15705
BibTeX
@article{Rivera2026,
author = {Rivera, Nahieli Preciado and Jenkins, Mara and Pham, Duy Anh and Garza Flores, Norma A and McCabe, Christina and Saini, Anuj and Randhawa, Gurpreet K and Tavakolian, Mandana and Sood, Saanvi and Belchos, Mackenzie and Jun, Isabella and Banquy, Xavier and Hoare, Todd},
title = {Injectable Dynamically Crosslinked Zwitterionic Hydrogels as a Viscosupplement for Osteoarthritis Treatment},
journal = {ACS Applied Materials & Interfaces},
year = {2026},
doi = {10.1021/acsami.6c15705}
}
EUVIMED